Liver Cancer Diagnostic Markers
- Summary
- Purdue University researchers have developed a diagnostic tool to detect liver cancer and the aggressiveness of the cancer. By looking for a protein profile, they can determine if the liver is likely to develop cancer because of the virus and the cancer's stage - precancerous, proliferative, or metastatic. Human samples and animal models were used to verify results.
- Technology Benefits
- Can diagnose the stage of liver cancerInitial human samples and animal models are providing a proof of conceptA better diagnostic tool can lead to better medicines and more effective treatments for liver cancer
- Technology Application
- Cancer DetectionMedical/HealthcarePharmaceuticals
- Detailed Technology Description
- Ourania AndrisaniPurdue Veterinary Medicine
- Countries
- United States
- Application No.
- None
- *Abstract
-
- *Background
- In July 2013, the World Health Organization estimated that over 400 million people suffer from chronic hepatitis B infection. The chronic infection can lead to a hepatocellular carcinoma or liver cancer. There currently is no effective treatment for chronic hepatitis B and liver cancer. The identification of biomarkers for liver cancer caused by this virus could lead to better medicines and provide doctors with a better understanding of the disease progression, as well as which treatment option gives the best outcome for the patient.
- *IP Issue Date
- None
- *IP Type
- Other Patent
- *Stage of Development
- Proof of Concept
- *Web Links
- Purdue Office of Technology CommercializationPurdueInnovation and EntrepreneurshipOurania AndrisaniPurdue Veterinary Medicine
- Country/Region
- USA
For more information, please click Here
